First use of icatibant (selective bradykinin receptor antagonist) in hereditary angioedema patients in the UK

被引：0
|
作者：
Karanam, S.
Demptser, J.
Longhurst, H.
Gompels, M.
机构：
[1] Southmead Hosp, Bristol, Avon, England
[2] St Bartholomews Hosp, London, England
来源：
CLINICAL AND EXPERIMENTAL ALLERGY | 2009年 / 39卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1943 / 1943
页数：1
相关论文
共 50 条
  • [1] Icatibant, a New Bradykinin-Receptor Antagonist, in Hereditary Angioedema
    Cicardi, M.
    Banerji, A.
    Bracho, F.
    Malbran, A.
    Rosenkranz, B.
    Riedl, M.
    Bork, K.
    Lumry, W.
    Aberer, W.
    Bier, H.
    Bas, M.
    Greve, J.
    Hoffmann, T. K.
    Farkas, H.
    Reshef, A.
    Ritchie, B.
    Yang, W.
    Grabbe, J.
    Kivity, S.
    Kreuz, W.
    Levy, R. J.
    Luger, T.
    Obtulowicz, K.
    Schmid-Grendelmeier, P.
    Bull, C.
    Sitkauskiene, B.
    Smith, W. B.
    Toubi, E.
    Werner, S.
    Anne, S.
    Bjorkander, J.
    Bouillet, L.
    Cillari, E.
    Hurewitz, D.
    Jacobson, K. W.
    Katelaris, C. H.
    Maurer, M.
    Merk, H.
    Bernstein, J. A.
    Feighery, C.
    Floccard, B.
    Gleich, G.
    Hebert, J.
    Kaatz, M.
    Keith, P.
    Kirkpatrick, C. H.
    Langton, D.
    Martin, L.
    Pichler, C.
    Resnick, D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (06): : 532 - 541
  • [2] BRADYKININ RECEPTOR 2 ANTAGONIST (ICATIBANT) FOR HEREDITARY ANGIOEDEMA TYPE III ATTACKS
    Bouillet, Laurence
    Boccon-Gibod, Isabelle
    Ponard, Denise
    Drouet, Christian
    Cesbron, Jean Yves
    Dumestre-Perard, Chantal
    Monnier, Nicole
    Lunardi, Joel
    Massot, Christian
    Gompel, Anne
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2009, 103 (05) : 448 - 448
  • [3] Icatibant, a potent and selective bradykinin B2 receptor antagonist, is effective in treating patients with Hereditary Angioedema (HAE)
    Levy, R. J.
    Goodman, S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S277 - S277
  • [4] Bradykinin receptor 2 antagonist (Icatibant) improves hereditary angioedema type III attacks
    Bouillet, L.
    Boccon-Gibod, I
    Ponard, D.
    Drouet, C.
    Dumestre-Perard, C.
    Cesbron, J.
    Monnier, N.
    Lunardi, J.
    Massot, C.
    Gompel, A.
    ALLERGY, 2010, 65 : 459 - 460
  • [5] Icatibant, a new bradykinin B2 receptor antagonist, for hereditary angioedema attacks
    Reshef, A.
    Liebovich, I.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) : S102 - S102
  • [6] Successful treatment of hereditary angioedema with bradykinin B2-receptor antagonist icatibant
    Krause, Karoline
    Metz, Martin
    Zuberbier, Torsten
    Maurer, Marcus
    Magerl, Markus
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2010, 8 (04): : 272 - 274
  • [7] The efficacy and safety of Icatibant, a selective bradykinin B2 receptor antagonist, for treating the symptoms of hereditary angioedema attacks
    Cicardi, M.
    ALLERGY, 2008, 63 : 474 - 474
  • [8] Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist icatibant
    Bas, M.
    Bier, H.
    Greve, J.
    Kojda, G.
    Hoffmann, T. K.
    ALLERGY, 2006, 61 (12) : 1490 - 1492
  • [9] Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant)
    Bork, Konrad
    Frank, Jorge
    Grundt, Boris
    Schlattmann, Peter
    Nussberger, Juerg
    Kreuz, Wolfhart
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (06) : 1497 - 1503
  • [10] Treatment of acute edema attacks in Hereditary Angioedema with a bradykinin receptor-2 antagonist (Icatibant)
    Grundt, B.
    Bork, K.
    Frank, J.
    Schlattmann, P.
    Nussbergger, J.
    Rosenkranz, B.
    Dong, L.
    Knolle, J.
    Kreuz, W.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S278 - S278
12345